Tirzepatide, a recently approved medication, is generating considerable excitement within the healthcare community. It works differently from traditional diabetes medications, targeting two receptors involved in sugar regulation and appetite . Initial trials have demonstrated significant efficacy in reducing blood levels in individuals with type 2